EUROFINS SCIENT Total Liabilities 2018-2024 | ERFSF
EUROFINS SCIENT total liabilities from 2018 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- EUROFINS SCIENT total liabilities for the quarter ending December 31, 2024 were $5.956B, a 8.14% increase year-over-year.
- EUROFINS SCIENT total liabilities for 2024 were $5.956B, a 4.32% decline from 2023.
- EUROFINS SCIENT total liabilities for 2023 were $6.225B, a 12.91% increase from 2022.
- EUROFINS SCIENT total liabilities for 2022 were $5.513B, a 0.1% increase from 2021.
| EUROFINS SCIENT Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $5,956 |
| 2023 | $6,225 |
| 2022 | $5,513 |
| 2021 | $5,507 |
| 2020 | $5,551 |
| 2019 | $5,516 |
| 2018 | $5,295 |
| 2017 | $3,787 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $5,956 |
| 2024-06-30 | $5,923 |
| 2023-06-30 | $5,725 |
| 2022-12-31 | $5,513 |
| 2021-12-31 | $5,507 |
| 2021-06-30 | $5,483 |
| 2020-12-31 | $5,551 |
| 2020-06-30 | $5,078 |
| 2019-12-31 | $5,516 |
| 2019-06-30 | $5,563 |
| 2018-12-31 | $5,295 |
| 2018-06-30 | $4,042 |
| 2017-12-31 | $3,787 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.999B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.286B | 26.31 |
| Elevance Health (ELV) | United States | $88.874B | 11.47 |
| CVS Health (CVS) | United States | $80.430B | 10.00 |
| Cencora (COR) | United States | $56.003B | 19.48 |
| DiDi Global (DIDIY) | China | $23.532B | 35.71 |
| Natera (NTRA) | United States | $22.361B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| Solventum (SOLV) | United States | $12.948B | 13.71 |
| CochLear (CHEOY) | Australia | $11.388B | 0.00 |
| ICON (ICLR) | Ireland | $11.234B | 10.44 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Revvity (RVTY) | United States | $10.840B | 18.66 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| HealthEquity (HQY) | United States | $9.646B | 42.25 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.522B | 22.63 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.107B | 13.93 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.139B | 24.38 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Alignment Healthcare (ALHC) | United States | $3.011B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.972B | 38.65 |
| Concentras Parent (CON) | United States | $2.824B | 16.32 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.126B | 9.06 |
| GeneDx Holdings (WGS) | United States | $2.056B | 79.20 |
| Premier (PINC) | United States | $1.889B | 14.33 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| PACS (PACS) | United States | $1.591B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.457B | 29.14 |
| Teladoc Health (TDOC) | United States | $1.275B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.210B | 9.21 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.087B | 16.97 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.678B | 10.26 |
| LifeMD (LFMD) | United States | $0.578B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| Enhabit (EHAB) | United States | $0.547B | 45.00 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.478B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Oncology Institute (TOI) | United States | $0.248B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.058B | 0.00 |
| ModivCare (MODV) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |